Workflow
AbbVie(ABBV)
icon
Search documents
Earnings Preview: AbbVie (ABBV) Q4 Earnings Expected to Decline
Zacks Investment Research· 2024-01-26 16:06
The market expects AbbVie (ABBV) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on F ...
Allergan Aesthetics Showcases Commitment to Individuality, Innovation, and Integrity at IMCAS World Congress 2024
Prnewswire· 2024-01-25 08:00
-- Expert-led symposium will explore key emerging themes in aesthetics, supported by injection session live from Allergan Aesthetics Center of Excellence in Italy -- -- New clinical data will be presented to support evolving Allergan Aesthetics portfolio -- -- 2024 marks 10 years of Allergan Medical Institute (AMI) and a decade of commitment to science and advanced education -- IRVINE, Calif., Jan. 25, 2024 /PRNewswire/ -- Allergan Aesthetics, the industry leader in aesthetics globally, continues to bring b ...
3 Dividend Stars Every Investor Should Own to Survive a Market Crash
InvestorPlace· 2024-01-24 23:44
One of the best reasons to invest in dividend stocks is how well they hold up when the stock market falls. Whether it’s a correction, a bear market, a recession, a depression or a full-on market crash, dividend-paying stocks outperform non-payers by a wide margin.The asset managers at Hartford Funds looked at the performance of the S&P 500 going all the way back to 1930. They found there was never a time where dividend stocks on the benchmark index had a losing decade. Further, if you invested $10,000 in th ...
Instead Of Buying A Rolex, I'm Investing $20,000 In These 2 Stocks, Yielding Up To 7%
Seeking Alpha· 2024-01-24 15:30
Manuel Augusto Moreno/Moment via Getty Images Introduction One of my hobbies is browsing the internet for fancy stuff I won't buy anyway. When I bought my first car, I spent weeks looking up my favorite BMW, which was followed by countless visits to dealerships that all failed to give me the price and quality I wanted - I mainly visited used car dealerships back then. The end of the story was that I was so done with visiting dealers that I went to the closest Toyota dealership, where I bought an affordable ...
7 Dividend Aristocrats That Will Pay You for Years to Come
InvestorPlace· 2024-01-23 04:19
Dividend Aristocrats are stocks that have been increasing dividends for the last 25 years. Inherently, these companies have deep stability and for that reason continue to be attractive.A lot has happened over that period: The.com bubble, the 2007 crash, and the pandemic are among the more prominent disruptions. Yet, these Dividend Aristocrats have continued to survive and thrive. ALl while increasing their dividends. That greater truth should attract investors who understand that such businesses make strong ...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks Investment Research· 2024-01-22 23:51
In the latest market close, AbbVie (ABBV) reached $165.39, with a +0.38% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.22%. Elsewhere, the Dow saw an upswing of 0.36%, while the tech-heavy Nasdaq appreciated by 0.32%.Heading into today, shares of the drugmaker had gained 6.34% over the past month, outpacing the Medical sector's gain of 2.3% and the S&P 500's gain of 1.61% in that time.The investment community will be closely monitoring the perf ...
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research· 2024-01-22 15:01
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this drugmaker have returned +6.3% over the past month versus the Zacks S&P 500 composite's +1.6% change. The Zacks Large Cap Pharmaceuticals industry, to which AbbVie belongs, has gained 6.7% over this period. Now the key question is: Where could the stock be headed in the near term?Although media reports or rumor ...
7 Highest Yielding Dividend Aristocrats Like AbbVie Are The Best 2024 Ideas Now
24/7 Wall Street· 2024-01-21 15:40
7 Highest Yielding Dividend Aristocrats Like AbbVie Are The Best 2024 Ideas Now ShutterstockProfessional / Shutterstock.com Since 1926, dividends have accounted for almost a third of the total return of the S&P 500, so regardless of whether the market is up, down, or flat, regular dividend payments from high-quality blue chip stocks provide investors with a much better chance for success. With inflation staying frustratingly strong and the potential for more stock market turbulence in the fourth quarter, ...
AbbVie (ABBV) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks Investment Research· 2024-01-16 23:48
The latest trading session saw AbbVie (ABBV) ending at $161.48, denoting a -0.57% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a loss of 0.37% for the day. At the same time, the Dow lost 0.62%, and the tech-heavy Nasdaq lost 0.19%.The drugmaker's stock has climbed by 5.85% in the past month, exceeding the Medical sector's gain of 4.61% and the S&P 500's gain of 1.56%.Analysts and investors alike will be keeping a close eye on the performance of AbbVie in its up ...
The 7 Highest Yielding 2024 Dividend Kings To Buy and Hold Forever
24/7 Wall Street· 2024-01-14 14:47
The 7 Highest Yielding 2024 Dividend Kings To Buy and Hold Forever ptasha / iStock via Getty Images Over the 22 months, interest rates have jumped from historical lows of 0% to the highest level since 2007 at 5.5%. 30 FHA Mortgages have jumped from 2.65% in January of 2021 to the current 7.07% rate. During that period, any stock that was the least sensitive to interest rates got hammered, and the damage trail covered several sectors.While it was a tough stretch for shareholders, 2024 could be the year man ...